123 related articles for article (PubMed ID: 36765481)
21. PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo.
Rahmani M; Aust MM; Benson EC; Wallace L; Friedberg J; Grant S
Clin Cancer Res; 2014 Sep; 20(18):4849-60. PubMed ID: 25070836
[TBL] [Abstract][Full Text] [Related]
22. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
Nie P; Hu W; Zhang T; Yang Y; Hou B; Zou Z
Cell Physiol Biochem; 2015; 35(6):2255-71. PubMed ID: 25895606
[TBL] [Abstract][Full Text] [Related]
23. PF-04691502, a dual PI3K/mTOR inhibitor has potent pre-clinical activity by inducing apoptosis and G1 cell cycle arrest in aggressive B-cell non-Hodgkin lymphomas.
Chen D; Mao C; Zhou Y; Su Y; Liu S; Qi WQ
Int J Oncol; 2016 Jan; 48(1):253-60. PubMed ID: 26549638
[TBL] [Abstract][Full Text] [Related]
24. Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma.
He Y; Li J; Ding N; Wang X; Deng L; Xie Y; Ying Z; Liu W; Ping L; Zhang C; Song Y; Zhu J
J Exp Clin Cancer Res; 2019 Feb; 38(1):86. PubMed ID: 30777096
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells.
Hong P; Wu M; Wei X; Xu X; Wu P; Gan L; Wu R; Jin J; Zhang K; Li D; Chen M; Wong W; Liu W; Zheng X
Bioorg Chem; 2024 Jan; 142():106937. PubMed ID: 37913583
[TBL] [Abstract][Full Text] [Related]
26. Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation.
Hayashi K; Nagasaki E; Kan S; Ito M; Kamata Y; Homma S; Aiba K
Cancer Sci; 2016 May; 107(5):682-9. PubMed ID: 26920337
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells.
Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC
Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644
[TBL] [Abstract][Full Text] [Related]
28. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
[No Abstract] [Full Text] [Related]
29. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis.
Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S
Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602
[TBL] [Abstract][Full Text] [Related]
30. [Effect of Asparaginase on Diffuse Large B-Cell Lymphoma Cell Apoptosis and Its Related Mechanism].
Gao X; Jiao J; Liu MD; Qin YY; Xu LY; Sang W; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1482-1489. PubMed ID: 31607302
[TBL] [Abstract][Full Text] [Related]
31. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
[TBL] [Abstract][Full Text] [Related]
32. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
[No Abstract] [Full Text] [Related]
33. [Mechanism of circZNF609 targeting miR-153 to regulate the proliferation and apoptosis of diffuse large B-cell lymphoma].
Yang CS; Lou Y; Ke QP; Xu XJ; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):238-245. PubMed ID: 35316873
[No Abstract] [Full Text] [Related]
34. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo.
Shi Y; He Z; Jia Z; Xu C
Mol Med Rep; 2016 Oct; 14(4):2921-8. PubMed ID: 27499118
[TBL] [Abstract][Full Text] [Related]
36. Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on human Burkitt's lymphoma Daudi cells in vitro.
Liu HL; Chen Y; Cui GH; Wu QL; He J
Acta Pharmacol Sin; 2005 Jul; 26(7):873-80. PubMed ID: 15960896
[TBL] [Abstract][Full Text] [Related]
37. Combined effect of
Li D; Jia YM; Cao PK; Wang W; Liu B; Li YL
J Cancer Res Ther; 2018; 14(7):1476-1481. PubMed ID: 30589026
[TBL] [Abstract][Full Text] [Related]
38. [Effects of Panax notoginseng saponins on proliferation, apoptosis and cell cycle of K562 cells in vitro and the mechanisms].
Li Y; Zhai W; Yang X; Ding J; Kan L
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(8):1103-9. PubMed ID: 26277504
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Polyethylene Glycol Complex Nanoparticles Combined with Gemcitabine Presents Improved Safety and Lasting Anti-Tumor Efficacy in a Murine Xenograft Model of Human Aggressive B Cell Lymphoma.
Liu Z; Wang S; Guo W; Zhang D; Yu H; Song W; Tang Z; Bai O
J Biomed Nanotechnol; 2021 Apr; 17(4):652-661. PubMed ID: 35057891
[TBL] [Abstract][Full Text] [Related]
40. [Methyl jasmonate induces apoptosis of human neuroblastoma cell line BE(2) -C and its mechanism].
Jiang GS; Tong QS; Zeng FQ; Hu B; Zheng LD; Cai JB; Liu Y
Yao Xue Xue Bao; 2008 Jun; 43(6):584-90. PubMed ID: 18822959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
